Advertisement

Author: Staff

Advertisement

Cambridge, Mass.-based InVivo Therapeutics enrolled a new patient into its INSPIRE study, which tests the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury.

Advertisement